Significance of SSA antibody in patients with CNS demyelinating diseases

被引：0
|
作者：
Park, J. H. [1 ]
Hwang, J. C. [1 ]
Kim, B. J. [1 ]
Lee, T. L. [2 ]
Lee, K. H. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea
[2] Haeundae Paik Hosp, Dept Neurol, Pusan, South Korea
来源：
MULTIPLE SCLEROSIS | 2010年 / 16卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1293 / 1293
页数：1
相关论文
共 50 条
  • [41] MOG-antibody associated demyelinating disease of the CNS: A clinical and pathological study in Chinese Han patients
    Zhou, Lei
    Huang, Yongheng
    Li, Haiqing
    Fan, Jie
    Zhangbao, Jingzi
    Yu, Hai
    Li, Yuxin
    Lu, Jiahong
    Zhao, Chongbo
    Lu, Chuanzhen
    Wang, Min
    Quan, Chao
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 305 : 19 - 28
  • [42] Antibody to Myelin Oligodendrocyte Glycoprotein in Adults with Inflammatory Demyelinating Disease of The CNS
    Kim, S. M.
    Kim, J. S.
    Kim, B. J.
    Baek, S. H.
    Sohn, S. Y.
    Woodhall, M.
    Kim, J. S.
    Kim, S. J.
    Park, K. S.
    Vincent, A.
    Lee, K. W.
    Waters, P.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 403 - 403
  • [43] FLUORESCENT ANTIBODY STUDIES OF EXPERIMENTAL AND HUMAN DEMYELINATING DISEASES
    SHERWIN, AL
    ROSE, B
    RICHTER, MR
    COSGROVE, JB
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1962, 86 (05) : 232 - &
  • [44] ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ANTIBODY IN SERA FROM PATIENTS WITH DEMYELINATING DISEASES
    SATO, S
    BABA, H
    INUZUKA, T
    MIYATAKE, T
    ACTA NEUROLOGICA SCANDINAVICA, 1986, 74 (02): : 115 - 120
  • [45] Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases
    Oksbjerg, N. R.
    Nielsen, S. D.
    Blinkenberg, M.
    Magyari, M.
    Sellebjerg, F.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [46] COVID-19 and the risk of CNS demyelinating diseases: a systematic review
    Lotan, I.
    Nishiyama, S.
    Manzano, G. S.
    Lydston, M.
    Levy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 934 - 935
  • [47] COVID-19 and the risk of CNS demyelinating diseases: A systematic review
    Lotan, Itay
    Nishiyama, Shuhei
    Manzano, Giovanna S.
    Lydston, Melissa
    Levy, Michael
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [48] QKI-V5 is downregulated in CNS inflammatory demyelinating diseases
    Lavon, Iris
    Leykin, Ina
    Charbit, Hanna
    Binyamin, Orli
    Brill, Livnat
    Ovadia, Haim
    Vaknin-Dembinsky, Adi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
  • [49] Heterogeneity of the mechanisms of nerve cell damage in demyelinating autoimmune diseases of the CNS
    Abdurasulova I.N.
    Klimenko V.M.
    Neuroscience and Behavioral Physiology, 2011, 41 (4) : 364 - 374
  • [50] Validation of a symptom-based questionnaire for pediatric CNS demyelinating diseases
    Waldman, Amy T.
    Yeshokumar, Anusha K.
    Lavery, Amy
    Liu, Geraldine
    Pineles, Stacy L.
    Repka, Michael X.
    Adang, Laura
    Narula, Sona
    Liu, Grant T.
    JOURNAL OF AAPOS, 2019, 23 (03): : 157 - 158
12345